Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...

Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" ...

Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...

A new Review published in the open-access journal Ferroptosis and Oxidative Stress highlights Z-nucleic acid-binding protein ...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of ...

Immunotherapy has joined surgery, radiation and chemotherapy as one of the major pillars of cancer treatment, one that sometimes results in lifelong protection against a cancer ever coming back. But ...

A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments SEATTLE — July 23, 2025 — A landmark study has ...

Rashes, itching and fatigue are among the common side effects of immunotherapy. An oncologist explains how the treatment ...

Immune checkpoint inhibitors, popularized by Allison and Honjo’s Nobel Prize, were one of the first cancer immunotherapies that gained FDA approval. In the 1990s, Allison and Honjo identified the ...

Researchers @hopkinskimmel and @HopkinsMed develop methods to predict which #livercancer patients do best with combination ...